Esther Hambrick
Acute Care · Huntsville, ALNPI 1861019697
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 373 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,473, more than ten times the $204 reported in 2021. Among acute care clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$821
- Sanofi$769
- Regeneron Healthcare Solutions, Inc.$728
- Insmed, Inc.$605
- Grifols USA, LLC$596
- plus $4K from 25 others
What the payments were for
- Food & beverage$8,244100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 65 | $1,045 |
| AstraZeneca | 34 | $821 |
| Sanofi | 28 | $769 |
| Regeneron Healthcare Solutions, Inc. | 29 | $728 |
| Insmed, Inc. | 27 | $605 |
| Grifols USA, LLC | 24 | $596 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $543 |
| Boehringer Ingelheim | 22 | $518 |
| Mylan Specialty L.p. | 17 | $361 |
| Harmony Biosciences LLC | 10 | $253 |
| Jazz Pharmaceuticals Inc. | 10 | $240 |
| Actelion Pharmaceuticals US, Inc. | 4 | $180 |
| Pulmonx Corporation | 2 | $173 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $165 |
| Axsome Therapeutics, Inc. | 10 | $159 |
| Verona Pharma, Inc. | 7 | $151 |
| Philips North America LLC | 7 | $124 |
| Amgen | 6 | $120 |
| Viatris Specialty LLC | 4 | $99 |
| Genentech USA, Inc. | 6 | $96 |
| Baxter Healthcare | 5 | $85 |
| Merck | 5 | $80 |
| Pfizer | 5 | $80 |
| Inogen, Inc. | 3 | $65 |
| United Therapeutics Corporation | 3 | $57 |
| Melinta Therapeutics, LLC | 2 | $38 |
| CSL Behring | 1 | $35 |
| Johnson & Johnson | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| Gilead | 1 | $18 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$238
- CHARTIS CATHETER$157
- ZEPHYR DELIVERY CATHETER$157
- ZEPHYR ENDOBRONCHIAL VALVE$157
- PULMONX CHARTIS TABLET CONSOLE$157
- UPTRAVI$121
- OPSUMIT$121
- AIRSUPRA$114
- TEZSPIRE$114
How this compares
$8,261 in reported general payments places this provider in the 90th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 25 | $309,618 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $43,835 |
| Spiriva RespimatTiotropium Bromide | 34 | $22,923 |
| Spiriva HandihalerTiotropium Bromide | 31 | $17,665 |
| Incruse ElliptaUmeclidinium Bromide | 26 | $12,005 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,929 |
| Advair HfaFluticasone Propion/Salmeterol | 26 | $10,073 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $8,839 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $8,538 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 368 | $8,205 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $8,189 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $8,163 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $6,304 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $6,191 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $5,451 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $518 | $349,24285 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta, Breo Ellipta | $1,045 | $70,983122 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $821 | $19,11847 claims |
| MerckDulera | $80 | $4,06312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 711 acute care providers in Alabama.
Other acute care in Huntsville
- April KlarHuntsville$13K
- Stephanie TateHuntsville$13K
- Kelly VazquezHuntsville$12K
- Summer SlaterHuntsville$12K
- Tiffany RentzHuntsville$11K
- Britanie MooreHuntsville$9K
- Trey WilsonHuntsville$8K
- Jessica BurkeenHuntsville$8K
- Alyssa EzellHuntsville$8K
- Ashley WrightHuntsville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.